ESCMID* guideline for the diagnosis and treatment of biofilm infections 2014

Clinical Microbiology and Infection

Volumn 21, Issue S1, 2015, Pages S1-S25

  Hoiby N ^a,b   Bjarnsholt, T ^a,b   Moser, C ^a   Bassi, G L ^c,d,e,f   Coenye, T ^g   Donelli, G ^h   Hall Stoodley, L ⁱ   Hola V ^j   Imbert, C ^k   Kirketerp Moller K ^l   Lebeaux, D ^m,n,o   Oliver, A ^p   Ullmann, A J ^q   Williams, C ^r  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c HOSPITAL CLÍNIC   (Spain)

^d INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

^f UNIVERSITY OF BARCELONA   (Spain)

^g GHENT UNIVERSITY   (Belgium)

^h IRCCS FONDAZIONE SANTA LUCIA   (Italy)

ⁱ OHIO STATE UNIVERSITY   (United States)

^j ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^k UNIVERSITÉ DE POITIERS   (France)

^l HVIDOVRE HOSPITAL   (Denmark)

^m INSTITUT PASTEUR   (France)

ⁿ UNIVERSITÉ PARIS DESCARTES   (France)

^o IMAGINE INSTITUTE   (France)

^p HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^q UNIVERSITY OF WÜRZBURG   (Germany)

^r UNIVERSITY OF THE WEST OF SCOTLAND   (United Kingdom)

^s ESGB)   (Switzerland)

more..

Author keywords

Biofilm; Biofilm diagnosis; Biofilm infections; Biofilm treatment; Biofilm associated infections; Biofilm based infections; Guidelines

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ANTIBODY RESPONSE; ARTICLE; BIOFILM INFECTION; BREAST IMPLANT; CANDIDA; CATHETER INFECTION; CYSTIC FIBROSIS; DEVICE INFECTION; ENDOTRACHEAL TUBE; HUMAN; IMMUNE RESPONSE; INDWELLING URINARY CATHETER; INFECTION PREVENTION; INTRAVASCULAR CATHETER; INTRAVENOUS CATHETER; LUNG INFECTION; MICROBIAL COLONIZATION; MICROBIOLOGICAL EXAMINATION; MICROORGANISM DETECTION; ORTHOPEDIC EQUIPMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; URINARY TRACT INFECTION; WOUND INFECTION; BIOFILM; CATHETER-RELATED INFECTIONS; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; PNEUMONIA, BACTERIAL; PROSTHESIS-RELATED INFECTIONS; SURGERY;

ANTI-BACTERIAL AGENTS; BIOFILMS; CATHETER-RELATED INFECTIONS; HUMANS; PNEUMONIA, BACTERIAL; PROSTHESIS-RELATED INFECTIONS; SURGICAL PROCEDURES, OPERATIVE; WOUND INFECTION;

EID: 84927616851     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2014.10.024     Document Type: Article

References (216)

1. Hall-Stoodley L., Stoodley P., Kathju S., Høiby N., Moser C., Costerton J.W., et al. Towards diagnostic guidelines for biofilm-associated infections. FEMS Immunol Med Microbiol 2012, 65:127-145.
2. Ramage G., Robertson S.N., Williams C. Strength in numbers: antifungal strategies against fungal biofilms. Int J Antimicrob Agents 2014, 43:114-120.
3. Lebeaux D., Chauhan A., Rendueles O., Beloin C. From invitro to invivo models of bacterial biofilm-related infections. Pathogens 2013, 288-356.
4. Bjarnsholt T., Ciofu O., Molin S., Givskov M., Høiby N. Applying insights from biofilm biology to drug development-can a new approach be developed?. Nat Rev Drug Discov 2013, 12:791-808.
5. Høiby N. Apersonal history of research on microbial biofilms and biofilm infections. Pathog Dis 2014, 70:205-211.
6. Høiby N., Bjarnsholt T., Givskov M., Molin S., Ciofu O. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 2010, 35:322-332.
7. Stoodley P., Sauer K., Davies D.G., Costerton J.W. Biofilms as complex differentiated communities. Annu Rev Microbiol 2002, 56:187-209.
8. Bjarnsholt T., Jensen P.O., Fiandaca M.J., Pedersen J., Hansen C.R., Andersen C.B., et al. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatr Pulmonol 2009, 44:547-558.
9. Kirketerp-Møller K., Jensen P.O., Fazli M., Madsen K.G., Pedersen J., Moser C., et al. Distribution, organization, and ecology of bacteria in chronic wounds. JClin Microbiol 2008, 46:2717-2722.
10. Bjarnsholt T., Alhede M., Alhede M., Eickhardt-Sorensen S.R., Moser C., Kuhl M., et al. The invivo biofilm. Trends Microbiol 2013, 21:466-474.
11. Gristina A.G., Costerton J.W. Bacterial adherence to biomaterials and tissue. The significance of its role in clinical sepsis. JBone Joint Surg Am 1985, 67:264-273.
12. Adair C.G., Gorman S.P., Feron B.M., Byers L.M., Jones D.S., Goldsmith C.E., et al. Implications of endotracheal tube biofilm for ventilator-associated pneumonia. Intensive Care Med 1999, 25:1072-1076.
13. Friedland D.R., Rothschild M.A., Delgado M., Isenberg H., Holzman I. Bacterial colonization of endotracheal tubes in intubated neonates. Arch Otolaryngol Head Neck Surg 2001, 127:525-528.
14. Gil-Perotin S., Ramirez P., Marti V., Sahuquillo J.M., Gonzalez E., Calleja I., et al. Implications of endotracheal tube biofilm in ventilator-associated pneumonia response: a state of concept. Crit Care 2012, 16:R93.
15. Inglis T.J., Lim T.M., Ng M.L., Tang E.K., Hui K.P. Structural features of tracheal tube biofilm formed during prolonged mechanical ventilation. Chest 1995, 108:1049-1052.
16. Mermel L.A., Allon M., Bouza E., Craven D.E., Flynn P., O'Grady N.P., et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 2009, 49:1-45.
17. Conway L.J., Larson E.L. Guidelines to prevent catheter-associated urinary tract infection: 1980 to 2010. Heart Lung 2012, 41:271-283.
18. Hooton T.M., Bradley S.F., Cardenas D.D., Colgan R., Geerlings S.E., Rice J.C., et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis 2010, 50:625-663.
19. Christensen L., Breiting V., Bjarnsholt T., Eickhardt S., Hogdall E., Janssen M., et al. Bacterial infection as a likely cause of adverse reactions to polyacrylamide hydrogel fillers in cosmetic surgery. Clin Infect Dis 2013, 56:1438-1444.
20. Bjarnsholt T., Tolker-Nielsen T., Givskov M., Janssen M., Chrsitensen L. Detection of bacteria by FISH in culture-negative soft tissue filler lesions. Dermatol Surg 2009, 35:1620-1624.
21. Rieger U.M., Mesina J., Kalbermatten D.F., Haug M., Frey H.P., Pico R., et al. Bacterial biofilms and capsular contracture in patients with breast implants. Br J Surg 2013, 100:768-774.
22. Wolcott R.D., Rhoads D.D., Bennett M.E., Wolcott B.M., Gogokhia L., Costerton J.W., et al. Chronic wounds and the medical biofilm paradigm. JWound Care 2010, 19. 45-50, 52.
23. Stoodley P., Kathju S., Hu F.Z., Erdos G., Levenson J.E., Mehta N., et al. Molecular and imaging techniques for bacterial biofilms in joint arthroplasty infections. Clin Orthop Relat Res 2005, 437:31-40.
24. Johannsson B., Taylor J., Clark C.R., Shamsuddin H., Beekmann S.E., Polgreen P. Treatment approaches to prosthetic joint infections: results of an Emerging Infections Network survey. Diagn Microbiol Infect Dis 2010, 66:16-23.
25. Cataldo M.A., Petrosillo N., Cipriani M., Cauda R., Tacconelli E. Prosthetic joint infection: recent developments in diagnosis and management. JInfect 2010, 61:443-448.
26. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005, 171:388-416.
27. Stickler D.J. Bacterial biofilms in patients with indwelling urinary catheters. Nat Clin Pract Urol 2008, 5:598-608.
28. Hola V., Ruzicka F. The formation of poly-microbial biofilms on urinary catheters. Urinary tract infections 2011, 153-172. InTech. P. Teneke (Ed.).
29. Viola G.M., Raad, Rolston K.V. Breast tissue expander-related infections: perioperative antimicrobial regimens. Infect Control Hosp Epidemiol 2014, 35:75-81.
30. Döring G., Conway S.P., Heijerman H.G., Hodson M.E., Høiby N., Smyth A., et al. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur Respir J 2000, 16:749-767.
31. Döring G., Høiby N. Early intervention and prevention of lung disease in cystic fibrosis: a European consensus. JCyst Fibros 2004, 3:67-91.
32. Kerem E., Conway S., Elborn S., Heijerman H. Standards of care for patients with cystic fibrosis: a European consensus. JCyst Fibros 2005, 4:7-26.
33. Heijerman H., Westerman E., Conway S., Touw D., Döring G. Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: a European consensus. JCyst Fibros 2009, 8:295-315.
34. Döring G., Flume P., Heijerman H., Elborn J.S. Treatment of lung infection in patients with cystic fibrosis: current and future strategies. JCyst Fibros 2012, 11:461-479.
35. Siddiq D.M., Darouiche R.O. New strategies to prevent catheter-associated urinary tract infections. Nat Rev Urol 2012, 9:305-314.
36. Bonkat G., Rieken M., Rentsch C.A., Wyler S., Feike A., Schafer J., et al. Improved detection of microbial ureteral stent colonisation by sonication. World J Urol 2011, 29:133-138.
37. Osmon D.R., Berbari E.F., Berendt A.R., Lew D., Zimmerli W., Steckelberg J.M., et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2013, 56:e1-e25.
38. Zimmerli W., Trampuz A., Ochsner P.E. Prosthetic-joint infections. NEngl J Med 2004, 351:1645-1654.
39. James G.A., Swogger E., Wolcott R., Pulcini E.D., Secor P., Sestrich J., et al. Biofilms in chronic wounds. Wound Repair Regen 2008, 16:37-44.
40. Bjarnsholt T., Kirketerp-Møller K., Jensen P.O., Madsen K.G., Phipps R., Krogfelt K., et al. Why chronic wounds will not heal: a novel hypothesis. Wound Repair Regen 2008, 16:2-10.
41. Inglis T.J., Millar M.R., Jones J.G., Robinson D.A. Tracheal tube biofilm as a source of bacterial colonization of the lung. JClin Microbiol 1989, 27:2014-2018.
42. Sottile F.D., Marrie T.J., Prough D.S., Hobgood C.D., Gower D.J., Webb L.X., et al. Nosocomial pulmonary infection: possible etiologic significance of bacterial adhesion to endotracheal tubes. Crit Care Med 1986, 14:265-270.
43. Berra L., Coppadoro A., Bittner E.A., Kolobow T., Laquerriere P., Pohlmann J.R., et al. Aclinical assessment of the Mucus Shaver: a device to keep the endotracheal tube free from secretions. Crit Care Med 2012, 40:119-124.
44. Kollef M.H., Afessa B., Anzueto A., Veremakis C., Kerr K.M., Margolis B.D., et al. Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial. JAMA 2008, 300:805-813.
45. Biel M.A., Sievert C., Usacheva M., Teichert M., Wedell E., Loebel N., et al. Reduction of endotracheal tube biofilms using antimicrobial photodynamic therapy. Lasers Surg Med 2011, 43:586-590.
46. Liu W., Zuo Z., Ma R., Zhang X. Effect of mechanical cleaning of endotracheal tubes with sterile urethral catheters to reduce biofilm formation in ventilator patients. Pediatr Crit Care Med 2013, 14:e338-e343.
47. Zhai Z., Li H., Qin A., Liu G., Liu X., Wu C., et al. Sonication fluid of prosthetic components for the diagnosis of infection after total joint arthroplasty: a meta-analysis. JClin Microbiol 2014 Feb 26.
48. Goddard A.F., Staudinger B.J., Dowd S.E., Joshi-Datar A., Wolcott R.D., Aitken M.L., et al. Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-airway specimens can misrepresent lung microbiota. Proc Natl Acad Sci USA 2012, 109:13769-13774.
49. Percival S.L., Hill K.E., Williams D.W., Hooper S.J., Thomas D.W., Costerton J.W. Areview of the scientific evidence for biofilms in wounds. Wound Repair Regen 2012, 20:647-657.
50. Lipsky B.A., Berendt A.R., Cornia P.B., Pile J.C., Peters E.J., Armstrong D.G., et al. Executive summary: 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2012, 54:1679-1684.
51. Trampuz A., Piper K.E., Jacobson M.J., Hanssen A.D., Unni K.K., Osmon D.R., et al. Sonication of removed hip and knee prostheses for diagnosis of infection. NEngl J Med 2007, 357:654-663.
52. Catelas I., Wimmer M.A., Utzschneider S. Polyethylene and metal wear particles: characteristics and biological effects. Semin Immunopathol 2011, 33:257-271.
53. Zadaka A., Gioe T., Gertner E. Acute crystal-induced arthritis following arthroplasty. JKnee Surg 2010, 23:17-20.
54. Parvizi J., Suh D.H., Jafari S.M., Mullan A., Purtill J.J. Aseptic loosening of total hip arthroplasty: infection always should be ruled out. Clin Orthop Relat Res 2011, 469:1401-1405.
55. Parvizi J., Jacovides C., Zmistowski B., Jung K.A. Definition of periprosthetic joint infection: is there a consensus?. Clin Orthop Relat Res 2011, 469:3022-3030.
56. Parvizi J., Zmistowski B., Berbari E.F., Bauer T.W., Springer B.D., Della Valle C.J., et al. New definition for periprosthetic joint infection. JArthroplasty 2011, 26:1136-1138.
57. Portillo M.E., Salvado M., Sorli L., Alier A., Martinez S., Trampuz A., et al. Multiplex PCR of sonication fluid accurately differentiates between prosthetic joint infection and aseptic failure. JInfect 2012, 65:541-548.
58. Vandercam B., Jeumont S., Cornu O., Yombi J.C., Lecouvet F., Lefevre P., et al. Amplification-based DNA analysis in the diagnosis of prosthetic joint infection. JMol Diagn 2008, 10:537-543.
59. Corvec S., Portillo M.E., Pasticci B.M., Borens O., Trampuz A. Epidemiology and new developments in the diagnosis of prosthetic joint infection. Int J Artif Organs 2012, 35:923-934.
60. Zimmerli W., Moser C. Pathogenesis and treatment concepts of orthopaedic biofilm infections. FEMS Immunol Med Microbiol 2012, 65:158-168.
61. Kolobow T., Berra L., Li B.G., Curto F. Novel system for complete removal of secretions within the endotracheal tube: the Mucus Shaver. Anesthesiology 2005, 102:1063-1065.
62. Mietto C., Foley K., Salerno L., Oleksak J., Pinciroli R., Goverman J., et al. Removal of endotracheal tube debris obstruction by a clearing secretion device. Respir Care 2013 Dec 24.
63. Berra L., De M.L., Yu Z.X., Laquerriere P., Baccarelli A., Kolobow T. Endotracheal tubes coated with antiseptics decrease bacterial colonization of the ventilator circuits, lungs, and endotracheal tube. Anesthesiology 2004, 100:1446-1456.
64. Wilson A., Gray D., Karakiozis J., Thomas J. Advanced endotracheal tube biofilm stage, not duration of intubation, is related to pneumonia. JTrauma Acute Care Surg 2012, 72:916-923.
65. Fernandez-Barat L., Li B.G., Ferrer M., Bosch A., Calvo M., Vila J., et al. Direct analysis of bacterial viability in endotracheal tube biofilm from a pig model of methicillin-resistant Staphylococcus aureus pneumonia following antimicrobial therapy. FEMS Immunol Med Microbiol 2012, 65:309-317.
66. Fernandez-Barat L., Ferrer M., Sierra J.M., Soy D., Guerrero L., Vila J., et al. Linezolid limits burden of methicillin-resistant Staphylococcus aureus in biofilm of tracheal tubes. Crit Care Med 2012, 40:2385-2389.
67. Brun-Buisson C., Abrouk F., Legrand P., Huet Y., Larabi S., Rapin M. Diagnosis of central venous catheter-related sepsis. Critical level of quantitative tip cultures. Arch Intern Med 1987, 147:873-877.
68. Maki D.G., Weise C.E., Sarafin H.W. Asemiquantitative culture method for identifying intravenous-catheter-related infection. NEngl J Med 1977, 296:1305-1309.
69. Douard M.C., Arlet G., Longuet P., Troje C., Rouveau M., Ponscarme D., et al. Diagnosis of venous access port-related infections. Clin Infect Dis 1999, 29:1197-1202.
70. Longuet P., Douard M.C., Arlet G., Molina J.M., Benoit C., Leport C. Venous access port-related bacteremia in patients with acquired immunodeficiency syndrome or cancer: the reservoir as a diagnostic and therapeutic tool. Clin Infect Dis 2001, 32:1776-1783.
71. Lebeaux D., Fernandez-Hidalgo N., Chauhan A., Lee S., Ghigo J.M., Almirante B., et al. Management of infections related to totally implantable venous-access ports: challenges and perspectives. Lancet Infect Dis 2014, 14:146-159.
72. Whitman E.D., Boatman A.M. Comparison of diagnostic specimens and methods to evaluate infected venous access ports. Am J Surg 1995, 170:665-669.
73. Bouza E., Alvarado N., Alcala L., Perez M.J., Rincon C., Munoz P. Arandomized and prospective study of 3 procedures for the diagnosis of catheter-related bloodstream infection without catheter withdrawal. Clin Infect Dis 2007, 44:820-826.
74. Guembe M., Martin-Rabadan P., Echenagusia A., Camunez F., Rodriguez-Rosales G., Simo G., et al. Value of superficial cultures for prediction of catheter-related bloodstream infection in long-term catheters: a prospective study. JClin Microbiol 2013, 51:3025-3030.
75. Blot F., Nitenberg G., Chachaty E., Raynard B., Germann N., Antoun S., et al. Diagnosis of catheter-related bacteraemia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures. Lancet 1999, 354:1071-1077.
76. Raad I., Hanna H.A., Alakech B., Chatzinikolaou I., Johnson M.M., Tarrand J. Differential time to positivity: a useful method for diagnosing catheter-related bloodstream infections. Ann Intern Med 2004, 140:18-25.
77. Ruhnke M., Rickerts V., Cornely O.A., Buchheidt D., Glockner A., Heinz W., et al. Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich-Society for Chemotherapy. Mycoses 2011, 54:279-310.
78. Chatzinikolaou I., Hanna H., Hachem R., Alakech B., Tarrand J., Raad I. Differential quantitative blood cultures for the diagnosis of catheter-related bloodstream infections associated with short- and long-term catheters: a prospective study. Diagn Microbiol Infect Dis 2004, 50:167-172.
79. Hachem R., Reitzel R., Borne A., Jiang Y., Tinkey P., Uthamanthil R., et al. Novel antiseptic urinary catheters for prevention of urinary tract infections: correlation of invivo and invitro test results. Antimicrob Agents Chemother 2009, 53:5145-5149.
80. Hola V., Ruzicka F., Horka M. Microbial diversity in biofilm infections of the urinary tract with the use of sonication techniques. FEMS Immunol Med Microbiol 2010, 59:525-528.
81. Morgan S.D., Rigby D., Stickler D.J. Astudy of the structure of the crystalline bacterial biofilms that can encrust and block silver Foley catheters. Urol Res 2009, 37:89-93.
82. Donelli G., Vuotto C. Biofilm-based infections in long-term care facilities. Future Microbiol 2014, 9:175-188.
83. Choe H.S., Son S.W., Choi H.A., Kim H.J., Ahn S.G., Bang J.H., et al. Analysis of the distribution of bacteria within urinary catheter biofilms using four different molecular techniques. Am J Infect Control 2012, 40:e249-e254.
84. Frank D.N., Wilson S.S., St Amand A.L., Pace N.R. Culture-independent microbiological analysis of foley urinary catheter biofilms. PLoS One 2009, 4:e7811.
85. Xu Y., Moser C., Al-Soud W.A., Sørensen S., Høiby N., Nielsen P.H., et al. Culture-dependent and -independent investigations of microbial diversity on urinary catheters. JClin Microbiol 2012, 50:3901-3908.
86. Malic S., Hill K.E., Hayes A., Percival S.L., Thomas D.W., Williams D.W. Detection and identification of specific bacteria in wound biofilms using peptide nucleic acid fluorescent in situ hybridization (PNA FISH). Microbiology 2009, 155:2603-2611.
87. Kobayashi H., Oethinger M., Tuohy M.J., Procop G.W., Bauer T.W. Improved detection of biofilm-formative bacteria by vortexing and sonication: a pilot study. Clin Orthop Relat Res 2009, 467:1360-1364.
88. Bjerkan G., Witso E., Bergh K. Sonication is superior to scraping for retrieval of bacteria in biofilm on titanium and steel surfaces invitro. Acta Orthop 2009, 80:245-250.
89. Kobayashi N., Bauer T.W., Tuohy M.J., Fujishiro T., Procop G.W. Brief ultrasonication improves detection of biofilm-formative bacteria around a metal implant. Clin Orthop Relat Res 2007, 457:210-213.
90. Penterman J., Nguyen D., Anderson E., Staudinger B.J., Greenberg E.P., Lam J.S., et al. Rapid evolution of culture-impaired bacteria during adaptation to biofilm growth. Cell Rep 2014, 6:293-300.
91. Pasquaroli S., Zandri G., Vignaroli C., Vuotto C., Donelli G., Biavasco F. Antibiotic pressure can induce the viable but non-culturable state in Staphylococcus aureus growing in biofilms. JAntimicrob Chemother 2013, 68:1812-1817.
92. Zandri G., Pasquaroli S., Vignaroli C., Talevi S., Manso E., Donelli G., et al. Detection of viable but non-culturable staphylococci in biofilms from central venous catheters negative on standard microbiological assays. Clin Microbiol Infect 2012, 18:E259-E261.
93. Siegman-Igra Y., Anglim A.M., Shapiro D.E., Adal K.A., Strain B.A., Farr B.M. Diagnosis of vascular catheter-related bloodstream infection: a meta-analysis. JClin Microbiol 1997, 35:928-936.
94. Slobbe L., El B.A., Boersma E., Rijnders B.J. Comparison of the roll plate method to the sonication method to diagnose catheter colonization and bacteremia in patients with long-term tunnelled catheters: a randomized prospective study. JClin Microbiol 2009, 47:885-888.
95. Lebeaux D., Larroque B., Gellen-Dautremer J., Leflon-Guibout V., Dreyer C., Bialek S., et al. Clinical outcome after a totally implantable venous access port-related infection in cancer patients: a prospective study and review of the literature. Medicine (Baltimore) 2012, 91:309-318.
96. Bouza E., Rojas L., Guembe M., Marin M., Anaya F., Luno J., et al. Predictive value of superficial cultures to anticipate tunneled hemodialysis catheter-related bloodstream infection. Diagn Microbiol Infect Dis 2014, 78:316-319.
97. Raad I., Hanna H., Maki D. Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet Infect Dis 2007, 7:645-657.
98. Safdar N., Fine J.P., Maki D.G. Meta-analysis: methods for diagnosing intravascular device-related bloodstream infection. Ann Intern Med 2005, 142:451-466.
99. Bouza E., Alcala L., Munoz P., Martin-Rabadan P., Guembe M., Rodriguez-Creixems M. Can microbiologists help to assess catheter involvement in candidaemic patients before removal?. Clin Microbiol Infect 2013, 19:E129-E135.
100. Percival S.L., Kite P., Eastwood K., Murga R., Carr J., Arduino M.J., et al. Tetrasodium EDTA as a novel central venous catheter lock solution against biofilm. Infect Control Hosp Epidemiol 2005, 26:515-519.
101. Ben-Ami R., Weinberger M., Orni-Wasserlauff R., Schwartz D., Itzhaki A., Lazarovitch T., et al. Time to blood culture positivity as a marker for catheter-related candidemia. JClin Microbiol 2008, 46:2222-2226.
102. Ullmann A.J., Akova M., Herbrecht R., Viscoli C., Arendrup M.C., Arikan-Akdagli S., et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT). Clin Microbiol Infect 2012, 18(Suppl.7):53-67.
103. Pressler T., Karpati F., Granstrom M., Knudsen P.K., Lindblad A., Hjelte L., et al. Diagnostic significance of measurements of specific IgG antibodies to Pseudomonas aeruginosa by three different serological methods. JCyst Fibros 2009, 8:37-42.
104. Artini M., Romano C., Manzoli L., Scoarughi G.L., Papa R., Meani E., et al. Staphylococcal IgM enzyme-linked immunosorbent assay for diagnosis of periprosthetic joint infections. JClin Microbiol 2011, 49:423-425.
105. Selan L., Passariello C., Rizzo L., Varesi P., Speziale F., Renzini G., et al. Diagnosis of vascular graft infections with antibodies against staphylococcal slime antigens. Lancet 2002, 359(9324):2166-2168.
106. Aanaes K., Johansen H.K., Poulsen S.S., Pressler T., Buchwald C., Høiby N. Secretory IgA as a diagnostic tool for Pseudomonas aeruginosa respiratory colonization. JCyst Fibros 2013, 12:81-87.
107. Rudkjøbing V.B., Thomsen T.R., Alhede M., Kragh K.N., Nielsen P.H., Johansen U.R., et al. True microbiota involved in chronic lung infection of cystic fibrosis patients found by culturing and 16S rRNA gene analysis. JClin Microbiol 2011, 49:4352-4355.
108. Schuetz P., Christ-Crain M., Thomann R., Falconnier C., Wolbers M., Widmer I., et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA 2009, 302:1059-1066.
109. Worthington T., Dunlop D., Casey A., Lambert R., Luscombe J., Elliott T. Serum procalcitonin, interleukin-6, soluble intercellular adhesin molecule-1 and IgG to short-chain exocellular lipoteichoic acid as predictors of infection in total joint prosthesis revision. Br J Biomed Sci 2010, 67:71-76.
110. Kizilbash Q.F., Petersen N.J., Chen G.J., Naik A.D., Trautner B.W. Bacteremia and mortality with urinary catheter-associated bacteriuria. Infect Control Hosp Epidemiol 2013, 34:1153-1159.
111. Høiby N., Johansen H.K., Ciofu O., Jensen P.O., Bjarnsholt T., Givskov M. Foreign body infections-biofilms and quorum sensing. Ugeskr Laeger 2007, 169:4163-4166.
112. Rodriguez-Tudela J.L., Arendrup M.C., Cuenca-Estrella M., Donnelly J.P., Lass-Florl C. EUCAST breakpoints for antifungals. Drug News Perspect 2010, 23:93-97.
113. Moskowitz S.M., Emerson J.C., McNamara S., Shell R.D., Orenstein D.M., Rosenbluth D., et al. Randomized trial of biofilm testing to select antibiotics for cystic fibrosis airway infection. Pediatr Pulmonol 2011, 46:184-192.
114. Moskowitz S.M., Foster J.M., Emerson J., Burns J.L. Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. JClin Microbiol 2004, 42:1915-1922.
115. Waters V., Ratjen F. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis. Cochrane Database Syst Rev 2012, 11:CD009528.
116. Chauhan A., Lebeaux D., Decante B., Kriegel I., Escande M.C., Ghigo J.M., et al. Arat model of central venous catheter to study establishment of long-term bacterial biofilm and related acute and chronic infections. PLoS One 2012, 7(5):e37281.
117. Warwick S., Wilks M., Hennessy E., Powell-Tuck J., Small M., Sharp J., et al. Use of quantitative 16S ribosomal DNA detection for diagnosis of central vascular catheter-associated bacterial infection. JClin Microbiol 2004, 42:1402-1408.
118. Larsen M.K., Thomsen T.R., Moser C., Høiby N., Nielsen P.H. Use of cultivation-dependent and -independent techniques to assess contamination of central venous catheters: a pilot study. BMC Clin Pathol 2008, 8:10.
119. Song Z., Borgwardt L., Høiby N., Wu H., Sørensen T.S., Borgwardt A. Prosthesis infections after orthopedic joint replacement: the possible role of bacterial biofilms. Orthop Rev (Pavia) 2013, 5:65-71.
120. Petronella P., Scorzelli M., Fiore A., Corbisiero M.C., Agresti E., Esposito S., et al. Antibiotic prophylaxis in catheter-associated urinary infections. New Microbiol 2012, 35:191-198.
121. Sayin K.S., Aybek Z., Tekin K., Okke D., Akalin S., Altintas S., et al. Is short course of antimicrobial therapy for asymptomatic bacteriuria before urologic surgical procedures sufficient?. JInfect Dev Ctries 2012, 6:143-147.
122. Karanlik H., Kurul S., Saip P., Unal E.S., Sen F., Disci R., et al. The role of antibiotic prophylaxis in totally implantable venous access device placement: results of a single-center prospective randomized trial. Am J Surg 2011, 202:10-15.
123. Di C I., Toro A., Pulvirenti E., Palermo F., Scibilia G., Cordio S. Could antibiotic prophylaxis be not necessary to implant totally implantable venous access devices? Randomized prospective study. Surg Oncol 2011, 20:20-25.
124. van de Wetering M.D., van Woensel J.B. Prophylactic antibiotics for preventing early central venous catheter Gram positive infections in oncology patients. Cochrane Database Syst Rev 2007, (1):CD003295.
125. O'Meara S., Cullum N., Majid M., Sheldon T. Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration. Health Technol Assess 2000, 4:1-237.
126. Howell-Jones R.S., Wilson M.J., Hill K.E., Howard A.J., Price P.E., Thomas D.W. Areview of the microbiology, antibiotic usage and resistance in chronic skin wounds. JAntimicrob Chemother 2005, 55:143-149.
127. Parvizi J., Saleh K.J., Ragland P.S., Pour A.E., Mont M.A. Efficacy of antibiotic-impregnated cement in total hip replacement. Acta Orthop 2008, 79:335-341.
128. Marschall J., Lane M.A., Beekmann S.E., Polgreen P.M., Babcock H.M. Current management of prosthetic joint infections in adults: results of an Emerging Infections Network survey. Int J Antimicrob Agents 2013, 41:272-277.
129. Pickard R., Lam T., Maclennan G., Starr K., Kilonzo M., McPherson G., et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short-term catheterisation in hospital: a multicentre randomised controlled trial. Lancet 2012, 380(9857):1927-1935.
130. Johnson J.R., Kuskowski M.A., Wilt T.J. Systematic review: antimicrobial urinary catheters to prevent catheter-associated urinary tract infection in hospitalized patients. Ann Intern Med 2006, 144:116-126.
131. Gaonkar T.A., Sampath L.A., Modak S.M. Evaluation of the antimicrobial efficacy of urinary catheters impregnated with antiseptics in an invitro urinary tract model. Infect Control Hosp Epidemiol 2003, 24:506-513.
132. Gorman S., Adair C., O'Neill F., Goldsmith C., Webb H. Influence of selective decontamination of the digestive tract on microbial biofilm formation on endotracheal tubes from artificially ventilated patients. Eur J Clin Microbiol Infect Dis 1993, 12:9-17.
133. Adair C.G., Gorman S.P., Byers L.M., Jones D.S., Feron B., Crowe M., et al. Eradication of endotracheal tube biofilm by nebulised gentamicin. Intensive Care Med 2002, 28:426-431.
134. Berra L., Kolobow T., Laquerriere P., Pitts B., Bramati S., Pohlmann J., et al. Internally coated endotracheal tubes with silver sulfadiazine in polyurethane to prevent bacterial colonization: a clinical trial. Intensive Care Med 2008, 34:1030-1037.
135. Olson M.E., Harmon B.G., Kollef M.H. Silver-coated endotracheal tubes associated with reduced bacterial burden in the lungs of mechanically ventilated dogs. Chest 2002, 121:863-870.
136. Rello J., Kollef M., Diaz E., Sandiumenge A., del C.Y., Corbella X., et al. Reduced burden of bacterial airway colonization with a novel silver-coated endotracheal tube in a randomized multiple-center feasibility study. Crit Care Med 2006, 34:2766-2772.
137. Afessa B., Shorr A.F., Anzueto A.R., Craven D.E., Schinner R., Kollef M.H. Association between a silver-coated endotracheal tube and reduced mortality in patients with ventilator-associated pneumonia. Chest 2010, 137:1015-1021.
138. Ye X., Rupnow M., Bastide P., Lafuma A., Ovington L., Jarvis W.R. Economic impact of use of chlorhexidine-impregnated sponge dressing for prevention of central line-associated infections in the United States. Am J Infect Control 2011, 39:647-654.
139. Timsit J.F., Mimoz O., Mourvillier B., Souweine B., Garrouste-Org, Alfandari S., et al. Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults. Am J Respir Crit Care Med 2012, 186:1272-1278.
140. Timsit J.F., Schwebel C., Bouadma L., Geffroy A., Garrouste-Org, Pease S., et al. Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial. JAMA 2009, 301:1231-1241.
141. Loveday H.P., Wilson J.A., Pratt R.J., Golsorkhi M., Tingle A., Bak A., et al. epic3: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. JHosp Infect 2014, 86(Suppl.1):S1-70.
142. Darouiche R.O., Raad, Heard S.O., Thornby J.I., Wenker O.C., Gabrielli A., et al. Acomparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. NEngl J Med 1999, 340:1-8.
143. Casey A.L., Mermel L.A., Nightingale P., Elliott T.S. Antimicrobial central venous catheters in adults: a systematic review and meta-analysis. Lancet Infect Dis 2008, 8:763-776.
144. Gilbert R.E., Harden M. Effectiveness of impregnated central venous catheters for catheter related blood stream infection: a systematic review. Curr Opin Infect Dis 2008, 21:235-245.
145. Desrousseaux C., Sautou V., Descamps S., Traore O. Modification of the surfaces of medical devices to prevent microbial adhesion and biofilm formation. JHosp Infect 2013, 85:87-93.
146. Campos R.P., do Nascimento M.M., Chula D.C., Riella M.C. Minocycline-EDTA lock solution prevents catheter-related bacteremia in hemodialysis. JAm Soc Nephrol 2011, 22:1939-1945.
147. Ferreira Chacon J.M., Hato de A.E., de Lourdes S.R., Lazzarin CO V., Alves B.C., Mello de Andrea M.L., et al. Randomized study of minocycline and edetic acid as a locking solution for central line (port-a-cath) in children with cancer. Chemotherapy 2011, 57:285-291.
148. Solomon L.R., Cheesbrough J.S., Bhargava R., Mitsides N., Heap M., Green G., et al. Observational study of need for thrombolytic therapy and incidence of bacteremia using taurolidine-citrate-heparin, taurolidine-citrate and heparin catheter locks in patients treated with hemodialysis. Semin Dial 2012, 25:233-238.
149. Betjes M.G., van A.M. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution. Nephrol Dial Transplant 2004, 19:1546-1551.
150. Allon M. Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution. Clin Infect Dis 2003, 36:1539-1544.
151. Simon A., Ammann R.A., Wiszniewsky G., Bode U., Fleischhack G., Besuden M.M. Taurolidine-citrate lock solution (TauroLock) significantly reduces CVAD-associated grampositive infections in pediatric cancer patients. BMC Infect Dis 2008, 8:102.
152. Dumichen M.J., Seeger K., Lode H.N., Kuhl J.S., Ebell W., Degenhardt P., et al. Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignancies. JHosp Infect 2012, 80:304-309.
153. Bisseling T.M., Willems M.C., Versleijen M.W., Hendriks J.C., Vissers R.K., Wanten G.J. Taurolidine lock is highly effective in preventing catheter-related bloodstream infections in patients on home parenteral nutrition: a heparin-controlled prospective trial. Clin Nutr 2010, 29:464-468.
154. Broom J.K., Krishnasamy R., Hawley C.M., Playford E.G., Johnson D.W. Arandomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of Catheter Associated infecTion in Haemodialysis patients-the HEALTHY-CATH trial. BMC Nephrol 2012, 13:146.
155. Sanders J., Pithie A., Ganly P., Surgenor L., Wilson R., Merriman E., et al. Aprospective double-blind randomized trial comparing intraluminal ethanol with heparinized saline for the prevention of catheter-associated bloodstream infection in immunosuppressed haematology patients. JAntimicrob Chemother 2008, 62:809-815.
156. Wales P.W., Kosar C., Carricato M., de S.N., Lang K., Avitzur Y. Ethanol lock therapy to reduce the incidence of catheter-related bloodstream infections in home parenteral nutrition patients with intestinal failure: preliminary experience. JPediatr Surg 2011, 46:951-956.
157. Slobbe L., Doorduijn J.K., Lugtenburg P.J., El B.A., Boersma E., van Leeuwen W.B., et al. Prevention of catheter-related bacteremia with a daily ethanol lock in patients with tunnelled catheters: a randomized, placebo-controlled trial. PLoS One 2010, 5(5):e10840.
158. Redelman C.V., Maduakolam C., Anderson G.G. Alcohol treatment enhances Staphylococcus aureus biofilm development. FEMS Immunol Med Microbiol 2012, 66:411-418.
159. Oliveira C., Nasr A., Brindle M., Wales P.W. Ethanol locks to prevent catheter-related bloodstream infections in parenteral nutrition: a meta-analysis. Pediatrics 2012, 129:318-329.
160. Novikov A., Lam M.Y., Mermel L.A., Casey A.L., Elliott T.S., Nightingale P. Impact of catheter antimicrobial coating on species-specific risk of catheter colonization: a meta-analysis. Antimicrob Resist Infect Control 2012, 1:40.
161. Walraven C.J., Lee S.A. Antifungal lock therapy. Antimicrob Agents Chemother 2013, 57:1-8.
162. Lai K.K., Fontecchio S.A. Use of silver-hydrogel urinary catheters on the incidence of catheter-associated urinary tract infections in hospitalized patients. Am J Infect Control 2002, 30:221-225.
163. Srinivasan A., Karchmer T., Richards A., Song X., Perl T.M. Aprospective trial of a novel, silicone-based, silver-coated foley catheter for the prevention of nosocomial urinary tract infections. Infect Control Hosp Epidemiol 2006, 27:38-43.
164. Zhao X., Drlica K. Restricting the selection of antibiotic-resistant mutant bacteria: measurement and potential use of the mutant selection window. JInfect Dis 2002, 185:561-565.
165. Vilchez F., Martinez-Pastor J.C., Garcia-Ramiro S., Bori G., Macule F., Sierra J., et al. Outcome and predictors of treatment failure in early post-surgical prosthetic joint infections due to Staphylococcus aureus treated with debridement. Clin Microbiol Infect 2011, 17:439-444.
166. Parvizi J., Gehrke T., Chen A.F. Proceedings of the International Consensus on Periprosthetic Joint Infection. Bone Joint J 2013, 95-B(11):1450-1452.
167. Funalleras G., Fernandez-Hidalgo N., Borrego A., Almirante B., Planes A.M., Rodriguez D., et al. Effectiveness of antibiotic-lock therapy for long-term catheter-related bacteremia due to Gram-negative bacilli: a prospective observational study. Clin Infect Dis 2011, 53:e129-e132.
168. Fernandez-Hidalgo N., Almirante B., Calleja R., Ruiz I., Planes A.M., Rodriguez D., et al. Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study. JAntimicrob Chemother 2006, 57:1172-1180.
169. Rijnders B.J., Van W.E., Vandecasteele S.J., Stas M., Peetermans W.E. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial. JAntimicrob Chemother 2005, 55:90-94.
170. Fortun J., Grill F., Martin-Davila P., Blazquez J., Tato M., Sanchez-Corral J., et al. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy. JAntimicrob Chemother 2006, 58:816-821.
171. del Pozo J.L., Garcia C.M., Hernaez S., Martinez A., Serrera A., Aguinaga A., et al. Effectiveness of teicoplanin versus vancomycin lock therapy in the treatment of port-related coagulase-negative staphylococci bacteraemia: a prospective case-series analysis. Int J Antimicrob Agents 2009, 34:482-485.
172. Fowler V.G., Sanders L.L., Sexton D.J., Kong L., Marr K.A., Gopal A.K., et al. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis 1998, 27:478-486.
173. Fowler V.G., Justice A., Moore C., Benjamin D.K., Woods C.W., Campbell S., et al. Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia. Clin Infect Dis 2005, 40:695-703.
174. Anaissie E.J., Rex J.H., Uzun O., Vartivarian S. Predictors of adverse outcome in cancer patients with candidemia. Am J Med 1998, 104:238-245.
175. Segarra-Newnham M., Martin-Cooper E.M. Antibiotic lock technique: a review of the literature. Ann Pharmacother 2005, 39:311-318.
176. Andes D.R., Safdar N., Baddley J.W., Playford G., Reboli A.C., Rex J.H., et al. Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin Infect Dis 2012, 54:1110-1122.
177. Nucci M., Colombo A.L., Silveira F., Richtmann R., Salomao R., Branchini M.L., et al. Risk factors for death in patients with candidemia. Infect Control Hosp Epidemiol 1998, 19:846-850.
178. Rex J.H., Bennett J.E., Sugar A.M., Pappas P.G., Serody J., Edwards J.E., et al. Intravascular catheter exchange and duration of candidemia. NIAID Mycoses Study Group and the Candidemia Study Group. Clin Infect Dis 1995, 21:994-996.
179. Nucci M., Anaissie E., Betts R.F., Dupont B.F., Wu C., Buell D.N., et al. Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials. Clin Infect Dis 2010, 51:295-303.
180. Pappas P.G., Kauffman C.A., Andes D., Benjamin D.K., Calandra T.F., Edwards J.E., et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009, 48:503-535.
181. Cornely O.A., Bassetti M., Calandra T., Garbino J., Kullberg B.J., Lortholary O., et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect 2012, 18(Suppl.7):19-37.
182. Cateau E., Berjeaud J.M., Imbert C. Possible role of azole and echinocandin lock solutions in the control of Candida biofilms associated with silicone. Int J Antimicrob Agents 2011, 37:380-384.
183. Toulet D., Debarre C., Imbert C. Could liposomal amphotericin B (L-AMB) lock solutions be useful to inhibit Candida spp. biofilms on silicone biomaterials?. JAntimicrob Chemother 2012, 67:430-432.
184. Bensel T., Stotz M., Borneff-Lipp M., Wollschlager B., Wienke A., Taccetti G., et al. Lactate in cystic fibrosis sputum. JCyst Fibros 2011, 10:37-44.
185. Hengzhuang W., Wu H., Ciofu O., Song Z., Høiby N. Pharmacokinetics/pharmacodynamics of colistin and imipenem on mucoid and nonmucoid Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 2011, 55:4469-4474.
186. Hengzhuang W., Wu H., Ciofu O., Song Z., Høiby N. Invivo pharmacokinetics/pharmacodynamics of colistin and imipenem in Pseudomonas aeruginosa biofilm infection. Antimicrob Agents Chemother 2012, 56:2683-2690.
187. Hengzhuang W., Ciofu O., Yang L., Wu H., Song Z., Oliver A., et al. High beta-lactamase levels change the pharmacodynamics of beta-lactam antibiotics in Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 2013, 57:196-204.
188. Lebrun E., Tomic-Canic M., Kirsner R.S. The role of surgical debridement in healing of diabetic foot ulcers. Wound Repair Regen 2010, 18:433-438.
189. Caputo W.J., Beggs D.J., DeFede J.L., Simm L., Dharma H. Aprospective randomised controlled clinical trial comparing hydrosurgery debridement with conventional surgical debridement in lower extremity ulcers. Int Wound J 2008, 5:288-294.
190. Sendi P., Zimmerli W. Antimicrobial treatment concepts for orthopaedic device-related infection. Clin Microbiol Infect 2012, 18:1176-1184.
191. Sherertz R.J., Boger M.S., Collins C.A., Mason L., Raad Comparative invitro efficacies of various catheter lock solutions. Antimicrob Agents Chemother 2006, 50:1865-1868.
192. Lepape A. Is there any microbiologically-based specificity of the management of catheter related infections?. Ann Fr Anesth Reanim 2005, 24:298-301.
193. Capdevila J.A., Gavalda J., Fortea J., Lopez P., Martin M.T., Gomis X., et al. Lack of antimicrobial activity of sodium heparin for treating experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique. Clin Microbiol Infect 2001, 7:206-212.
194. Jørgensen B., Karlsmark T., Vogensen H., Haase L., Lundquist R. Apilot study to evaluate the safety and clinical performance of Leucopatch, an autologous, additive-free, platelet-rich fibrin for the treatment of recalcitrant chronic wounds. Int J Low Extrem Wounds 2011, 10:218-223.
195. Döring G., Meisner C., Stern M. Adouble-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients. Proc Natl Acad Sci USA 2007, 104:11020-11025.
196. Ullmann A.J., Cornely O.A., Donnelly J.P., Akova M., Arendrup M.C., Arikan-Akdagli S., et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases. Clin Microbiol Infect 2012, 18(Suppl.7):1-8.
197. Høiby N. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey. Acta Pathol Microbiol Scand 1977, 262(Suppl.C):3-96.
198. Baltimore R.S., Christie C.D., Smith G.J. Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Implications for the pathogenesis of progressive lung deterioration. Am Rev Respir Dis 1989, 140:1650-1661.
199. Lefmann M., Schweickert B., Buchholz P., Gobel U.B., Ulrichs T., Seiler P., et al. Evaluation of peptide nucleic acid-fluorescence in situ hybridization for identification of clinically relevant mycobacteria in clinical specimens and tissue sections. JClin Microbiol 2006, 44:3760-3767.
200. Hall-Stoodley L., Hu F.Z., Gieseke A., Nistico L., Nguyen D., Hayes J., et al. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA 2006, 296:202-211.
201. Nistico L., Kreft R., Gieseke A., Coticchia J.M., Burrows A., Khampang P., et al. Adenoid reservoir for pathogenic biofilm bacteria. JClin Microbiol 2011, 49:1411-1420.
202. Homøe P., Bjarnsholt T., Wessman M., Sørensen H.C., Johansen H.K. Morphological evidence of biofilm formation in Greenlanders with chronic suppurative otitis media. Eur Arch Otorhinolaryngol 2009, 266:1533.
203. Marrie T.J., Nelligan J., Costerton J.W. Ascanning and transmission electron microscopic study of an infected endocardial pacemaker lead. Circulation 1982, 66:1339-1341.
204. Waar K., Degener J.E., van Luyn M.J., Harmsen H.J. Fluorescent in situ hybridization with specific DNA probes offers adequate detection of Enterococcus faecalis and Enterococcus faecium in clinical samples. JMed Microbiol 2005, 54:937-944.
205. Costerton J.W., Post J.C., Ehrlich G.D., Hu F.Z., Kreft R., Nistico L., et al. New methods for the detection of orthopedic and other biofilm infections. FEMS Immunol Med Microbiol 2011, 61:133-140.
206. Veeh R.H., Shirtliff M.E., Petik J.R., Flood J.A., Davis C.C., Seymour J.L., et al. Detection of Staphylococcus aureus biofilm on tampons and menses components. JInfect Dis 2003, 188:519-530.
207. Marrie T.J., Noble M.A., Costerton J.W. Examination of the morphology of bacteria adhering to peritoneal dialysis catheters by scanning and transmission electron microscopy. JClin Microbiol 1983, 18:1388-1398.
208. Marrie T.J., Costerton J.W. Scanning and transmission electron microscopy of in situ bacterial colonization of intravenous and intraarterial catheters. JClin Microbiol 1984, 19:687-693.
209. Stoodley P., Braxton E.E., Nistico L., Hall-Stoodley L., Johnson S., Quigley M., et al. Direct demonstration of Staphylococcus biofilm in an external ventricular drain in a patient with a history of recurrent ventriculoperitoneal shunt failure. Pediatr Neurosurg 2010, 46:127-132.
210. Parsa K., Schaudinn C., Gorur A., Sedghizadeh P.P., Johnson T., Tse D.T., et al. Demonstration of bacterial biofilms in culture-negative silicone stent and jones tube. Ophthal Plast Reconstr Surg 2010, 26:426-430.
211. Gristina A.G., Oga M., Webb L.X., Hobgood C.D. Adherent bacterial colonization in the pathogenesis of osteomyelitis. Science 1985, 228(4702):990-993.
212. Marrie T.J., Costerton J.W. Mode of growth of bacterial pathogens in chronic polymicrobial human osteomyelitis. JClin Microbiol 1985, 22:924-933.
213. Sedghizadeh P.P., Kumar S.K., Gorur A., Schaudinn C., Shuler C.F., Costerton J.W. Microbial biofilms in osteomyelitis of the jaw and osteonecrosis of the jaw secondary to bisphosphonate therapy. JAm Dent Assoc 2009, 140:1259-1265.
214. Cryer J., Schipor I., Perloff J.R., Palmer J.N. Evidence of bacterial biofilms in human chronic sinusitis. ORL J Otorhinolaryngol Relat Spec 2004, 66:155-158.
215. Li H., Wang D., Sun X., Hu L., Yu H., Wang J. Relationship between bacterial biofilm and clinical features of patients with chronic rhinosinusitis. Eur Arch Otorhinolaryngol 2012, 269:155-163.
216. Stapleton F., Dart J. Pseudomonas keratitis associated with biofilm formation on a disposable soft contact lens. Br J Ophthalmol 1995, 79:864-865.